Navigation Links
NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock
Date:10/25/2007

ned from Dawson James Securities, Inc., Attn: Investment Banking, 925 South Federal Highway, 6th Floor, Boca Raton, FL 33432, telephone number (866) 928-0928. Copies of the Canadian prospectus may be obtained from Dundee Securities Corporation, 1 Adelaide St. E., Suite 2700, Toronto, Ontario M4T 1J9; Attn: Equity Capital Markets, E-mail: ecm@dundeesecurities.com.

About NovaBay

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus (MRSA). NovaBay has entered into a licensing and research collaboration agreement with an affiliate of Alcon, Inc. for use of the Aganocide compounds in the eye, ear and sinus and in contact lens solutions and a license agreement with an affiliate of Kinetic Concepts, Inc. for the use of NovaBay's NeutroPhase product in woundcare applications.

NovaBay(TM), Aganocide(TM) and NeutroPhase(TM) are trademarks of NovaBay Pharmacuticals, Inc. All other trademarks and trade names are the property of their respective owners.

Safe Harbor Statement

This release contains forward-looking statements, which are based upon management's current expectations, assumptions, estimates, projections and beliefs. These statements include, but are not limited to, statements regarding the development and potential benefits of, and the mar
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Corn prices and ethanol: Are the markets flaky - or working as they should?
4. Alliant to add 100 megawatts of wind power by 2005, raise gas prices
5. QBIs PreserveX product passes initial test
6. 2006: A great biotech financing year, unless you were going public!
7. TomoTherapys 100th radiology system reaches public sector
8. With patents and research tools, when is private really public?
9. Brady Corp. raises $137 million in public offering
10. In public attitudes about taxes and spending, Wisconsin is Jekyll and Hyde
11. Republican sees nothing wrong with Doyles use of executive order
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
...HAI On day four of Gov. Jim Doyle,s trade mission...gy and software company, signed two major agreemen...rship is expected to result in new investments wor...f new jobs in Wisconsin. , ,"This deal shows the t...nies to play a role as China is rapidly upgrading ...
... are three locations on an Internet search page: t...me fits onto a single page and other times its 100...: If your Web sites identity is successful, only t...le to potential customers. However, if its submerg...ysterious undercurrents or worse, rest at the bott...
...ON The national AFL-CIO has taken its Show on the...ing too many jobs overseas, the labor union organi... the Jobs . , ,Laid-off workers, students, a pries...mong the 51 people who toured Wisconsin and seven ...y the Bush administration to promote a growing eco...
...n on investment has become a national obsession. L...t. But in many organizations ROI has become more o...ot always clear who is in the drivers seat. Becaus... through organizations, squashing otherwise approp...of the way. Some organizations throw away the keys...
Other Biology Technology:Does your web site have visibility? 2Does your web site have visibility? 3Theres a surprising, and positive, side to the offshore jobs debate 2Theres a surprising, and positive, side to the offshore jobs debate 3Make ROI work for you 2Make ROI work for you 3
(Date:10/6/2008)...ELPHIA Moderate consumption of red wine may decre... report in the October issue of Cancer Epidemiolo...ican Association for Cancer Research. , "An ant...f lung cancer, particularly among smokers," said C...rmanente ,Department of Research and Evaluation i...
(Date:10/6/2008)... Hughes Medical Institute researchers have develop...ted Down syndrome and two other serious chromosoma...f confirmed in larger trials, they say, the test w...ive prenatal tests such as amniocentesis that pose...ong known that a pregnant woman,s blood contains s...
(Date:10/6/2008)...ne,s for the birds. , A study by biologists at Wa...re diverse a bird population is in an area, the le...us (WNV). , Now, let,s hear it for the birds. , ... species in your backyard, you have much lower ris...n, doctoral candidate in biology in Arts & Science...
(Date:10/6/2008)... What does a mixture of two different kinds of ce...? The same basic force causes both mixtures to sep...onclusion of a new three-dimensional computer mode...tson, assistant professor of physics at Vanderbilt...of Waterloo in Canada that is described in the Oct...
Breaking Biology News(10 mins):Red wine may lower lung cancer risk 2New blood test for Down syndrome 2New blood test for Down syndrome 3New blood test for Down syndrome 4Study: Bird diversity lessens human exposure to West Nile Virus 2Surface tension drives segregation within cell mixtures 2AMDL Updates Q2 and FY2008 Guidance 6883 1AMDL Updates Q2 and FY2008 Guidance 6883 2AMDL Updates Q2 and FY2008 Guidance 6883 3GKSS membranes reduce air pollution in Beijing 4306 1GKSS membranes reduce air pollution in Beijing 4306 2China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 1China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 2China Biologic Products Begins Annual Maintenance of its Production Facilities 6880 3VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 1VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 2
... a newly marketed vaccine promises to drastically ... major cause of cervical cancer, a new discovery b...could some day help the millions of people already...d cancer. , One study found that 75 percent of sex...had, an HPV infection, while 10,000 women annually...
... flies, ability to discern one sex from another ma... of nerve cells, and the number of receptors is co... University of Illinois at Chicago researchers hav...ate, perceive and learn to debilitating illnesses ...strophy, post-traumatic stress syndrome and schizo...
...standing how the human brain learns to perceive ob...ience. In 2003, Pawan Sinha, a professor at the M...initiative with the hopes of shedding some light o...s "Project Prakash" is to find, treat, and study c...e study that resulted from this project appears in...
...tists at Queensland University of Technology are o... to protect women against contracting the most com...ernational vaccine company Sanofi-Pasteur has awar...ontinue its research into Chlamydia and work towar...lescent women. , Professor Peter Timms, from QU...
Other Biology News:Synthetic peptide targets latent papilloma virus infections 2Synthetic peptide targets latent papilloma virus infections 3Synthetic peptide targets latent papilloma virus infections 4Bisexual fruit flies show new role for neurochemical 2Chlamydia vaccine a step closer to reality 2
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface.
Antibeta-lactoglobulin monoclonal antibody(CD-2)
MAb to Vasopressin Preservative: NaN3
...α, clone 8G8/5 GenBank Accession Number : N...lpha/gamma fusion protein corresponding to residue...0 of human AP-2γ Formulation: 0.1M Tris-glyc... the addition of glycerol to 30% Quality Assurance...
Biology Products: